Cardiometabolic multimorbidity
Cardiometabolic multimorbidity has been studied in 2 papers since 2022: 2 observational studies in people; 1 in the past year. The newest paper, May 22, 2026: “Systemic inflammation mediates the link between cardiometabolic multimorbidity and cognitive function among older U.S. adults: evidence from NHANES”.
2 papers study it3 findingsUpdated
See all 2 papers on cardiometabolic multimorbidity
At a glance
The findings reach people, from one lab or study. 2 independent labs in 1 country.
“Compared with participants without multimorbidity, cardiometabolic multimorbidity (hazard ratios [HR] = 2.20, 95% confidence intervals [CI]: 2.14 - 2.26)”
None of its findings points the other way.
- 2 independent labs in 1 country
- Funders: Centers for Disease Control and Prevention and 4 more
- Humans2
What did studies of cardiometabolic multimorbidity find?
2Studies of cardiometabolic multimorbidity measured 2 outcomes: neutrophil-to-lymphocyte ratio and digit Symbol Substitution Test performance.
Neutrophil-to-lymphocyte ratio
upin humans1
1 study
Neutrophil-to-lymphocyte ratio
upin humans1
Cardiometabolic multimorbidity is linked with higher neutrophil-to-lymphocyte ratio in humans (β = 0.075 (95% CI 0.040 to -0.111)).
“and higher systemic inflammation (NLR: β = 0.075, 95% CI: 0.040 to -0.111, P < .001)”
Humans
Medicine
Digit Symbol Substitution Test performance
downin humans1
1 study
Digit Symbol Substitution Test performance
downin humans1
Cardiometabolic multimorbidity is linked with worse digit Symbol Substitution Test performance in humans (β = -6.57 (95% CI -8.44 to -4.70)).
“CMM was significantly associated with poorer Digit Symbol Substitution Test (DSST) performance (β = -6.57, 95% confidence interval [CI]: -8.44 to -4.70, P < .001)”
Humans
Medicine
What is cardiometabolic multimorbidity linked with?
1Studies link cardiometabolic multimorbidity with mortality.
Mortality
upin humans1HR 2.2
1 study
Mortality
upin humans1HR 2.2
Cardiometabolic multimorbidity is linked with a higher risk of mortality in humans (compared with participants without multimorbidity) (HR 2.20, 95% CI 2.14–2.26).
“Compared with participants without multimorbidity, cardiometabolic multimorbidity (hazard ratios [HR] = 2.20, 95% confidence intervals [CI]: 2.14 - 2.26)”
Humanscompared with participants without multimorbiditymedian 10.8 years of follow-upn = 512,723
Multimorbidity patterns and association with mortality in 0.5 million Chinese adults
Chinese medical journal
Funding
1 grant since 2026Natural Science Foundation of Hunan Province